Emily Donnelly

Associate Director, Labeling & Disclosures at Sarepta Therapeutics

Speaker

Emily Donnelly, Associate Director, Labeling & Disclosures, at Sarepta, is responsible for public disclosure of clinical trial registrations, results, plain language summaries and redacted documents. She is also the global labeling lead for two of Sarepta’s marketed products. She has worked in the biotechnology industry for almost 10 years, with the last 5 years in this transparency role. Prior to industry, Emily worked in academic research, focusing on the areas of addiction and maternal and child health. Emily holds an MPH in Healthcare Administration from Boston University and a BA in Neuroscience from Bates College.